Sanjay Patel

6.4k total citations
67 papers, 2.3k citations indexed

About

Sanjay Patel is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Sanjay Patel has authored 67 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Sanjay Patel's work include Diabetes Treatment and Management (36 papers), Diabetes Management and Research (24 papers) and Pancreatic function and diabetes (15 papers). Sanjay Patel is often cited by papers focused on Diabetes Treatment and Management (36 papers), Diabetes Management and Research (24 papers) and Pancreatic function and diabetes (15 papers). Sanjay Patel collaborates with scholars based in United Kingdom, Germany and United States. Sanjay Patel's co-authors include Hans‐Juergen Woerle, Maximilian von Eynatten, Julio Rosenstock, Odd Erik Johansen, Andrew Lewin, Dacheng Liu, Uli C. Broedl, Renee Kaste, Dietmar Neubacher and Sudipta Bhattacharya and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Investigation.

In The Last Decade

Sanjay Patel

67 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sanjay Patel United Kingdom	21	1.9k	829	788	514	303	67	2.3k
Gregory T. Golm United States	26	2.3k 1.2×	800 1.0×	1.0k 1.3×	459 0.9×	367 1.2×	52	2.5k
Thomas Meinicke Germany	22	2.5k 1.3×	971 1.2×	1.0k 1.3×	317 0.6×	382 1.3×	35	2.8k
Ping Yan China	21	1.3k 0.7×	601 0.7×	757 1.0×	226 0.4×	343 1.1×	55	2.3k
Robert Josse Canada	10	1.7k 0.9×	665 0.8×	730 0.9×	426 0.8×	251 0.8×	17	2.2k
Frans Van de Werf Belgium	8	1.9k 1.0×	666 0.8×	733 0.9×	313 0.6×	267 0.9×	16	2.3k
Samuel S. Engel United States	5	1.7k 0.9×	549 0.7×	654 0.8×	276 0.5×	246 0.8×	6	1.9k
Craig Wilson United States	15	3.0k 1.5×	958 1.2×	1.1k 1.4×	630 1.2×	400 1.3×	28	3.3k
Alfonso T. Perez United States	7	2.8k 1.4×	882 1.1×	1.3k 1.7×	464 0.9×	349 1.2×	8	3.2k
Monica Ligueros‐Saylan United States	25	2.0k 1.0×	1.1k 1.3×	760 1.0×	588 1.1×	240 0.8×	51	3.1k
Egon Pfarr Germany	12	1.5k 0.8×	489 0.6×	497 0.6×	217 0.4×	196 0.6×	20	1.8k

Countries citing papers authored by Sanjay Patel

Since Specialization

Citations

This map shows the geographic impact of Sanjay Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjay Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjay Patel more than expected).

Fields of papers citing papers by Sanjay Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjay Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjay Patel. The network helps show where Sanjay Patel may publish in the future.

Co-authorship network of co-authors of Sanjay Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjay Patel. A scholar is included among the top collaborators of Sanjay Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjay Patel. Sanjay Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weerakkody, Ruwan, Gowthanan Santhirakumaran, Laura Bremner, et al.. (2021). Predictors of outcome in diabetic patients undergoing infrapopliteal endovascular revascularization for chronic limb-threatening ischemia. Journal of Vascular Surgery. 75(2). 618–624. 7 indexed citations

Bearne, Lindsay, Melissa Galea Holmes, Saskia Eddy, et al.. (2019). Motivating Structured walking Activity in people with Intermittent Claudication (MOSAIC): protocol for a randomised controlled trial of a physiotherapist-led, behavioural change intervention versus usual care in adults with intermittent claudication. BMJ Open. 9(8). e030002–e030002. 10 indexed citations

Saratzis, Athanasios, Ioannis Paraskevopoulos, Sanjay Patel, et al.. (2019). Supervised Exercise Therapy and Revascularization for Intermittent Claudication. JACC: Cardiovascular Interventions. 12(12). 1125–1136. 28 indexed citations

Seet, Christopher, Teresa Szyszko, Tommaso Donati, et al.. (2019). Streptococcus pneumoniae as a Cause of Mycotic and Infected Aneurysms in Patients without Respiratory Features: Challenging Diagnoses Aided by 16S PCR. Annals of Vascular Surgery. 60. 475.e11–475.e17. 3 indexed citations

Riopel, Matthew, Jong Bae Seo, Gautam Bandyopadhyay, et al.. (2018). Chronic fractalkine administration improves glucose tolerance and pancreatic endocrine function. Journal of Clinical Investigation. 128(4). 1458–1470. 30 indexed citations

C.W., Ronald, Stefano Del Prato, Baptist Gallwitz, et al.. (2017). Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial. Journal of Diabetes Investigation. 9(3). 579–586. 11 indexed citations

Inagaki, Nobuya, Wayne Huey‐Herng Sheu, David R. Owens, et al.. (2016). Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials. Journal of Diabetes and its Complications. 30(8). 1622–1630. 5 indexed citations

Katsanos, Konstantinos, Stavros Spiliοpoulos, Sanjay Patel, et al.. (2016). Peripheral Stent Thrombosis Leading to Acute Limb Ischemia and Major Amputation: Incidence and Risk Factors in the Aortoiliac and Femoropopliteal Arteries. CardioVascular and Interventional Radiology. 40(3). 351–359. 20 indexed citations

DeFronzo, Ralph A., Andrew Lewin, Sanjay Patel, et al.. (2015). Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin. Diabetes Care. 38(3). 384–393. 244 indexed citations

10.

Zinman, Bernard, Bo Åhrén, Dietmar Neubacher, et al.. (2015). Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis. Canadian Journal of Diabetes. 40(1). 50–57. 26 indexed citations

11.

Patel, Sanjay, Jason Constantinou, Dominic Simring, et al.. (2015). Results of complex aortic stent grafting of abdominal aortic aneurysms stratified according to the proximal landing zone using the Society for Vascular Surgery classification. Journal of Vascular Surgery. 62(2). 319–325.e2. 25 indexed citations

12.

Patel, Sanjay, et al.. (2014). Synthesis, characterization and chelating properties of novel heterocyclic azo dyes containing ligand.. Journal of chemical and pharmaceutical research. 6(11). 364–368. 1 indexed citations

13.

Saha, Prakash, John Hughes, Ashish Patel, et al.. (2014). Medium-Term Outcomes Following Endovascular Repair of Infrarenal Abdominal Aortic Aneurysms with an Unfavourable Proximal Neck. CardioVascular and Interventional Radiology. 38(4). 840–845. 6 indexed citations

14.

Lehrke, Michael, Nikolaus Marx, Sanjay Patel, et al.. (2014). Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies. Clinical Therapeutics. 36(8). 1130–1146. 51 indexed citations

15.

Gross, Jorge Luiz, James A. Rogers, William R. Gillespie, et al.. (2013). A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment of type 2 diabetes mellitus. BMJ Open. 3(3). e001844–e001844. 29 indexed citations

16.

Barnett, Anthony, Holger Huisman, Russell Jones, et al.. (2013). Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial. The Lancet. 382(9902). 1413–1423. 140 indexed citations

17.

Prato, Stefano Del, Marja‐Riitta Taskinen, David R. Owens, et al.. (2013). Efficacy and safety of linagliptin in subjects with type 2 diabetes mellitus and poor glycemic control: Pooled analysis of data from three placebo-controlled phase III trials. Journal of Diabetes and its Complications. 27(3). 274–279. 16 indexed citations

18.

Johansen, Odd Erik, Dietmar Neubacher, Maximilian von Eynatten, Sanjay Patel, & Hans‐Juergen Woerle. (2012). Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme. Cardiovascular Diabetology. 11(1). 3–3. 191 indexed citations

19.

Thrasher, James, et al.. (2012). Black/African American patients with type 2 diabetes mellitus: study design and baseline patient characteristics from a randomized clinical trial of linagliptin. Expert Opinion on Pharmacotherapy. 13(17). 2443–2452. 9 indexed citations

20.

Gallwitz, Baptist, Julio Rosenstock, T. Rauch, et al.. (2012). 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial. The Lancet. 380(9840). 475–483. 277 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact